Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» aripiprazole lauroxil
aripiprazole lauroxil
5 Big FDA Decisions Expected in August
24/7 Wall St
Thu, 08/6/15 - 02:58 pm
FDA
Exelixis
vemurafenib
aripiprazole lauroxil
Alkermes
evolocumab
Amgen
Bristol-Myers Squibb
Opdivo
Clovis Oncology
rociletinib
Alkermes' Pipeline Development Impresses, Key Updates Ahead
Yahoo/Reuters
Tue, 07/22/14 - 08:54 am
Alkermes
Invega Sustenna
ALKS 3831
aripiprazole lauroxil
ALKS 5461
New Alkermes Schizophrenia Drug -- An Important Advance With Social Benefits
Forbes
Wed, 06/18/14 - 10:11 am
aripiprazole lauroxil
schizophrenia
Alkermes
The Biggest Biotech Wins of the Week
Motley Fool
Thu, 04/17/14 - 07:46 am
biotech
Puma Biotechnology
aripiprazole lauroxil
Alkermes
neratinib
Roche
Herceptin
bemaciclib
breast cancer
Eli Lilly
Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data
Yahoo/Zacks.com
Wed, 04/16/14 - 10:22 am
MannKind
Alkermes
Gilead Sciences
ledipasvir
AbbVie
Afrezza
aripiprazole lauroxil
Pharmacyclics
Imbruvica
Alkermes' schizophrenia drug meets main goal of late-stage study
Yahoo/Reuters
Tue, 04/8/14 - 09:04 am
Alkermes
schizophrenia
aripiprazole lauroxil
Alkermes announces advances with its late-stage CNS pipeline
Yahoo/Fly on the Wall
Wed, 01/8/14 - 08:37 am
Alkermes
aripiprazole lauroxil
schizophrenia
ALKS 5461
major depressive disorder